Atrium Therapeutics, Inc. Common Stock

Stock Chart, Company Information, and Scan Results

$14.03(as of Apr 16, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Atrium Therapeutics, Inc. Common Stock Company Information, Fundamentals, and Technical Indicators

Stock Price$14.03
Ticker SymbolRNA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees511
CountyUSA
Market Cap$225.6M
EBIDTA-49.3M
10-Day Moving Average13.71
P/E Ratio-3.90
20-Day Moving Average13.46
Forward P/E Ratio0.00
50-Day Moving Average32.79
Earnings per Share-4.48
200-Day Moving Average49.78
Profit Margin-5,595.93%
RSI26.21
Shares Outstanding15.5M
ATR1.00
52-Week High73.06
Volume275,086
52-Week Low11.95
Most Recent Support Level12.63
Book Value207.3M
Most Recent Resistance Level14.60
P/B Ratio9.32
Upper Keltner15.72
P/S Ratio103.02
Lower Keltner11.20
Debt-to-Equity Ratio15.72
Next Earnings Date05/12/2026
Cash Surplus228.2M
Next Ex-Dividend DateUnknown

Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California.

Atrium Therapeutics, Inc. Common Stock In Our Stock Scanner

As of Apr 17, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Oversold Stocks Scan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Mean ReversionScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.